Skip to main content

MorphaBond News (Page 2)

FDA Medwatch Alert: Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9 percent Sodium Chloride by by Pharmakon Pharmaceuticals: Recall - Super-potent Product

ISSUE: FDA is alerting health care professionals of a voluntary recall of morphine sulfate 0.5 mg/mL preservative free in 0.9% sodium chloride, 1 mL syringe, CII, for intravenous use made and...

FDA Approves MorphaBond (morphine sulfate) Extended-Release Tablets with Abuse-Deterrent Properties

VALLEY COTTAGE, N.Y., Oct. 5, 2015 /PRNewswire/ – Inspirion Delivery Technologies LLC (“Inspirion”) announced that the United States Food and Drug Administration (FDA) has approved MorphaBond™ (morphi...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Pain, Pain